Although cancer can be cured if detected early and treated effectively, it is still a leading
cause of death worldwide. Tumor development can be limited by an appropiate immune …

Patients with metastatic cancers often require radiotherapy (RT) as a palliative therapy for
cancer pain. RT can, however, also induce systemic antitumor effects outside of the …

One of the challenges of radiation oncology in the era of personalized medicine is
identification of biomarkers associated with individual radiosensitivity. The aim of research …

Background The search for factors beyond the radiotherapy dose that could identify patients
more at risk of developing radio-induced toxicity is essential to establish personalised …

Glioblastoma is the most malignancy tumor generated from the central nervous system
along with median survival time less than 14.6 months. Pentraxin 3 has been proved its …

The lack of hormone receptors in triple negative breast cancer (TNBC) is associated with the
inefficacy of anti‑estrogen chemotherapies, leaving fewer options for patient treatment and …

Radiotherapy is an effective regimen for cancer treatment alone or combined with
chemotherapy or immunotherapy. The direct effect of radiotherapy involves radiation …

Neoadjuvant chemoradiotherapy (CRT) resistance is a complex phenomenon and it
remains a major problem for patients with a priori resistant tumor. Therefore, there is a strong …

Prostate cancer (PC) and Ovarian cancer (OC) are two of the most common types of cancer
that affect the reproductive systems of older men and women. These cancers are associated …

Simple Summary Brain tumors, including glioblastoma (GB), pose a significant health
concern globally, with high mortality rates despite current therapies. Pentraxin 3 (PTX3) is a …